Retinoic acid combined with GM-CSF induces morphological changes with segmented nuclei in human myeloblastic leukemia ML-1 cells

Anticancer Res. 1997 May-Jun;17(3C):1951-5.

Abstract

The effects of all-trans retinoic acid (ATRA), either alone or in combination with GM-CSF, on the induction of differentiation of a human myeloblastic leukemia cell line, ML-1, were investigated. ATRA alone caused only slight induction of NBT-reducing activity even at a high concentration (10(-7) M), but when combined with GM-CSF, it led to remarkable increase in the induction of NBT-reducing activity. Synergistic effect of both agents was also observed on morphological changes and the inhibition of cell proliferation. When ATRA or GM-CSF was used alone, neither parameter was changed substantially for long periods of up to 9 days. However, the combination of both agents induced remarkable morphological changes with segmented nuclei and also suppressed DNA-synthesizing activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Nucleus / drug effects*
  • Cell Nucleus / pathology
  • Cell Nucleus / ultrastructure
  • DNA Replication / drug effects
  • DNA, Neoplasm / biosynthesis
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Humans
  • Leukemia, Myeloid, Acute
  • Time Factors
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • DNA, Neoplasm
  • Tretinoin
  • Granulocyte-Macrophage Colony-Stimulating Factor